SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-18-000082
Filing Date
2018-03-16
Accepted
2018-03-16 10:00:11
Documents
51
Period of Report
2018-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt013118form10q.htm 10-Q 895776
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 23237
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 16036
4 EXHIBIT 32 ex32.htm EX-32 4070
  Complete submission text file 0001607062-18-000082.txt   2961910

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20180131.xml EX-101.INS 339653
6 XBRL SCHEMA FILE gnbt-20180131.xsd EX-101.SCH 36068
7 XBRL CALCULATION FILE gnbt-20180131_cal.xml EX-101.CAL 27445
8 XBRL DEFINITION FILE gnbt-20180131_def.xml EX-101.DEF 131012
9 XBRL LABEL FILE gnbt-20180131_lab.xml EX-101.LAB 216421
10 XBRL PRESENTATION FILE gnbt-20180131_pre.xml EX-101.PRE 195380
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 18694438
SIC: 2834 Pharmaceutical Preparations